- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 417.89M sh |
| Long Term Debt | Q1 2025 · Apr 4, 2025 | $3.35B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $3.35B |
| Short Term Investments | Q1 2025 · Apr 4, 2025 | $250M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $300M |
| Stockholders Equity | Q1 2025 · Apr 4, 2025 | $8.03B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $8.8B |
| Current Liabilities | Q1 2025 · Apr 4, 2025 | $1.28B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.33B |
| Total Liabilities | Q1 2025 · Apr 4, 2025 | $5.21B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.28B |
| Current Assets | Q1 2025 · Apr 4, 2025 | $6.33B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $6.75B |
| Total Assets | Q1 2025 · Apr 4, 2025 | $13.25B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $14.09B |
| Shares Diluted | Q1 2025 · Mar 29, 2024 | 436.5M sh |
| Stock Repurchased | Q1 2025 · Mar 29, 2024 | $100M |
| Capex restated | Q1 2025 · Mar 29, 2024 | $233.9M |
| Operating Cash Flow | Q1 2025 · Mar 29, 2024 | $498.7M |
| Cash And Equivalents | Q1 2025 · Mar 29, 2024 | $2.61B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $2.48B |
| Eps Diluted | Q1 2025 · Mar 29, 2024 | $1.04 |
| Eps Basic | Q1 2025 · Mar 29, 2024 | $1.06 |
| Sga Expense | Q1 2025 · Mar 29, 2024 | $95.3M |
| Net Income | Q1 2025 · Mar 29, 2024 | $453M |
| Operating Income | Q1 2025 · Mar 29, 2024 | $525.2M |
| Gross Profit | Q1 2025 · Mar 29, 2024 | $853.6M |
| Cost Of Revenue | Q1 2025 · Mar 29, 2024 | $1.01B |
| Revenue | Q1 2025 · Mar 29, 2024 | $1.86B |